SCHEMBL93206

SCHEMBL93206

COc1ccc(C(=O)c2ccc(O)cc2O)c(O)c1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.89
RAB9A P51151 2/20 0.89
CYP3A4 P08684 6/20 0.75
HPGD P15428 5/20 0.75
LMNA P02545 4/20 0.75
CYP2C19 P33261 3/20 0.75
CYP1A2 P05177 2/20 0.75
PGR P06401 2/20 0.75
SLC6A2 P23975 2/20 0.75
ALOX15 P16050 2/20 0.75
ADORA3 P0DMS8 1/20 0.75
AR P10275 1/20 0.75
CHRM1 P11229 1/20 0.75
TBXA2R P21731 1/20 0.75
ADRA1A P35348 1/20 0.75
HIF1A Q16665 1/20 0.75
ALDH1A1 P00352 4/20 0.68
MAPK1 P28482 4/20 0.68
CYP2D6 P10635 1/20 0.68
PDE4A P27815 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30900821 1.00 NPC1 (0.89) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL1348833 1.00 NPC1 (0.89) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL29419872 1.00 NPC1 (0.89) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL1514997 0.94 NPC1 (1.00) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL29365072 0.94 NPC1 (1.00) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL38652 0.94 NPC1 (1.00) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL10453973 0.92 NPC1 (0.96) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL29380756 0.92 NPC1 (0.96) NPC1RAB9ACYP3A4HPGDLMNA
SCHEMBL2526579 0.92 NPC1 (0.96) NPC1RAB9ACYP3A4HPGDLMNA
Dioxybenzone SCHEMBL5011376 0.92 HPGD (0.91) NPC1RAB9ACYP3A4HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10619098-B2 Ultraviolet light absorbers TRANSITIONS OPTICAL, INC. (US) 2020-04-14 US disclosed
EP-3201292-B1 ULTRAVIOLET LIGHT ABSORBERS TRANSITIONS OPTICAL INC (US) 2018-08-01 EP disclosed
EP-2428540-B1 Coating composition SHINETSU CHEMICAL CO (JP) 2018-02-21 EP disclosed
US-9862806-B2 Plastic article for automotive glazing SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-01-09 US disclosed
US-20170275534-A1 ULTRAVIOLET LIGHT ABSORBERS TRANSITIONS OPTICAL, INC. 2017-09-28 US disclosed
EP-3201292-A1 ULTRAVIOLET LIGHT ABSORBERS Transitions Optical, Inc. (US) 2017-08-09 EP disclosed
EP-2607413-B1 Plastic Substrate for Automotive Glazing and Its Repairing Method SHINETSU CHEMICAL CO (JP) 2017-06-21 EP disclosed
WO-2016053662-A1 ULTRAVIOLET LIGHT ABSORBERS TRANSITIONS OPTICAL, INC. (US) 2016-04-07 WO disclosed
EP-2426175-B1 Plastic article for automotive glazing SHINETSU CHEMICAL CO (JP) 2014-07-23 EP disclosed
US-8642672-B2 Coating composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-02-04 US disclosed
US-20120059080-A1 COATING COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-08 US disclosed
EP-2426175-A1 Plastic article for automotive glazing Shin-Etsu Chemical Co., Ltd. (JP) 2012-03-07 EP disclosed
EP-2300599-A4 AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSLYTRANSFERASE AMERICAN STEM CELL INC (US) 2011-11-23 EP disclosed
US-8052900-B2 Reactive UV absorber, UV-screen film-forming curable coating solution, UV-screen film, and substrate having UV-screening function SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-11-08 US disclosed
EP-2182032-B1 Reactive UV absorber, UV-screen film-forming curable coating solution, UV-screen film, and substrate having UV-screening function SHINETSU CHEMICAL CO (JP) 2011-10-05 EP disclosed
US-20100108960-A1 REACTIVE UV ABSORBER, UV-SCREEN FILM-FORMING CURABLE COATING SOLUTION, UV-SCREEN FILM, AND SUBSTRATE HAVING UV-SCREENING FUNCTION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-05-06 US disclosed
EP-2182032-A1 Reactive UV absorber, UV-screen film-forming curable coating solution, UV-screen film, and substrate having UV-screening function SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-05-05 EP disclosed
US-4525504-A 1,4-CYCLOHEXANDEICARBOXYLIC ACID AND 2,2,4,4-TETRAMETHYL-1,3-CYCLOBUTANEDIOL, UV AND HINDERED AMINE STABILIZERS EASTMAN KODAK COMPANY (US) 1985-06-25 US disclosed
US-4524165-A 1,4-CYCLOHEXANEDICARBOXYLIC ACID AND 1,4-CYCLOHEXANE DIOL MONOMERS; POLYALKYLENE GLCOLS; STABILIZER MIXTURE EASTMAN KODAK COMPANY (US) 1985-06-18 US disclosed
US-4323710-A A NONAQUEOUS SOLVENT OF POLYOXYETHYLENE GLYCOL OR ITS ALKYLATED DERIVATIVES GAF CORPORATION (US) 1982-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10619098-B2 Ultraviolet light absorbers ERCC1, MCM4, ERCC4 NPC1 1292/4885RAB9A 3167/4885CYP3A4 189/4885
US-20170275534-A1 ULTRAVIOLET LIGHT ABSORBERS MCM4, ERCC1, ERCC4 NPC1 939/4885RAB9A 3917/4885CYP3A4 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.